Login / Signup

Application of Tumor Burden Score for predicting conversion outcome in patients with initially unresectable colorectal liver metastases after first-line systemic therapy.

Jian-Hong PengYujun LiuWeihao LiYuzhu LinHui SunZhizhong PanXiaojun WuWenhua FanJunzhong Lin
Published in: Therapeutic advances in gastroenterology (2021)
TBS should be applied in clinical practice to predict conversion outcome in patients with initially unresectable CRLM.
Keyphrases
  • liver metastases
  • clinical practice
  • locally advanced
  • squamous cell carcinoma
  • stem cells
  • mesenchymal stem cells
  • radiation therapy
  • bone marrow
  • cell therapy